It accelerates tendon fibroblast outgrowth, increases cell survival under stress, and promotes cell migration, likely through the activation of the FAK-paxillin pathway
BPC-157 has not been proven safe or effective for any condition and is not eligible for inclusion on the 503B Bulks List for compounding. FDA Review Memorandum, 2023 In other words, BPC157 does not meet FDA standards for legal use in clinical practice
BPC-157 is commonly studied in relation to: Tendon and ligament recovery mechanisms Muscle tissue repair models Angiogenesis (blood vessel formation) Inflammatory pathway modulation Because recovery plays a major role in sustaining training intensity, BPC-157 is often positioned as a supportive peptide within muscle-building research stacks
If glycine inclusion increases cost significantly, it is probably not worth the premium given the limited evidence for meaningful benefit at the doses used
Its studied as a selective NNMT inhibitor in laboratory settings
Thinking about using peptides like BPC-157, CJC-1295, or Ipamorelin around shoulder surgery